Journal article

Phase III comparison of vitespen, an autologous tumor-derived heat shock protein gp96 peptide complex vaccine, with physician's choice of treatment for stage IV melanoma: The C-100-21 study group

Alessandro Testori, Jon Richards, Eric Whitman, G Bruce Mann, Jose Lutzky, Luis Camacho, Giorgio Parmiani, Giulio Tosti, John M Kirkwood, Axel Hoos, Lianng Yuh, Renu Gupta, Pramod K Srivastava

Journal of Clinical Oncology | AMER SOC CLINICAL ONCOLOGY | Published : 2008